T HE sympathetic nervous system directly influences vascular resistance through the interaction of catecholamines with specific receptors associated with the vascular smooth muscle cells of muscular arteries and arterioles. In blood vessels, catecholamine-induced constriction is mediated by a-adrenergic receptors. In recent years, important advances have been made in the understanding of adrenergic receptors through the use of radioactive ligands that bind selectively to these receptors, thus permitting their direct characterization. 1 This experimental approach has revealed that adre-nergic receptors are distinct molecular entities 2 subject to physiologic regulation 9 and pathologic alteration, 4 and thus, are potentially inportant loci of biologic control. Radioligand binding assays have been used to study adrenergic receptors in a great number of target tissues and cells in culture. 1 The role of adrenergic receptors in modulating the variable vascular responsiveness to catecholamines observed under different physiologic" and pathophysiologic conditions, 8 ' 7 however, has not been investigated directly with these techniques.
Two technical limitations have hindered progress in the definition of the regulatory role of the vascular aadrenergic receptor. First, radioactive ligands of high specificity and affinity for a-adrenergic receptors and of suitable specific activity for the assay of relatively small amounts of tissue have only recently become available." Second, since arterial walls are structurally complex, and contain connective tissue, neural elements, and endothelial cells in addition to smooth muscle, it has been difficult to obtain fractions of vessel walls sufficiently enriched in smooth muscle to permit assay of adrenergic receptors. This 12 It has been stressed, however, that blood vessels from various parts of the circulation exhibit considerable histologic, physiologic, and pharmacologic heterogeneity.
"
18 Thus, this approach of using a large, fibroelastic, conduit-type vessel may not be applicable to the study of adrenergic receptor physiology in highly innervated, reactive muscular arteries of the type that contributes to vascular resistance. In addition, there is a need for such studies in a small laboratory animal such as the rat, for it can be readily subjected to hormonal manipulation and has been genetically inbred to produce a model of hypertension that appears to have a neurogenic component.
1 ' As an initial approach to the study of the physiology and biochemistry of adrenergic receptors in muscular arteries, we have identified [ J H]-DHEC binding sites that have the characteristics of a-adrenergic receptors in a particulate fraction from rat mesenteric arteries. Data obtained through the use of subtype-selective antagonists suggest that these receptors are predominantly of the ^-subtype mediating vascular smooth muscle contraction. 17 
Methods

Materials
We obtained ['HJ-DHEC from New England Nuclear (Boston, MA). It had a specific activity of 38.8 Ci/mmol and was greater than 98% pure on thin-layer chromatography in two solvent systems (chloroform:ethanol:acetic acid, 9:5:1, and chloroform: benzene: ethanol: ammonium hydroxide, 4:2:1:0.1). We stored ['HJ-DHEC in the dark in ethanol at -10°C. Immediately prior to use, the ['HJ-DHEC was diluted to the desired concentration with distilled water in a test tube wrapped in aluminum foil.
Phentolamine-HCL was obtained from CIBA Pharmaceutical Co. * Male Sprague-Dawley rats (300-350 g) (Charles River Laboratories, Wilmington, MA) were sacrificed by a blow to the head and cervical dislocation. The small intestine was doubly ligated at the proximal duodenum and terminal ileum, and cut between ligatures. The superior mesenteric vascular arcade was severed near its origin at the aorta and transferred, still attached to the small intestine, into ice-cold phosphate-buffered saline on the surface of a chilled Petri dish. The entire vascular arcade was then freed from its attachments to the bowel. The mesenteric vein, fat, and lymph nodes were removed from the artery by blunt dissection. Four arteries at a time were placed in an ice-cold 0.25 M sucrose solution (pH 6.1, unbuffered) in a Potter-Elvehjem homogenizer, and the fatty adventitial tissues removed with two gentle strokes of a specially ground, tapered Teflon pestle (clearance, 0.016 in.). Twelve arteries cleaned in this fashion were then combined in 40 ml of an ice-cold 0.25 M sucrose solution in a 50 ml beaker and coarsely minced with scissors. The tissue was transferred to a 125 ml Erlenmeyer flask, and another 20 ml of 0.25 M sucrose solution was added. The mix was then homogenized with a Brinkman Polytron (setting 8, 10 sec X 2) and poured into two 40 ml tubes that were centrifuged at 1500 X g for 10 minutes at 4°C. The supernatant was centrifuged at 100,000 X g for 30 minutes at 4°C in a Beckman ultracentrifuge. The supernatant was discarded, and any remaining fat on the sides of the tube was removed with a cottontipped applicator. The precipitate was resuspended in assay buffer (5 mM MgCl,, 50 mM Tris-HCl, pH 7.55) to a final protein concentration of 1.5-2.0 mg/ml. The mesenteric arteries from 12 300-g rats yielded approximately 3.8 mg of particulate fraction protein.
Radioligand Binding Assay
The ['HJ-DHEC binding assay previously described 1 ' for a-adrenergic receptors was modified to improve reproducibility when assaying the relatively small amount of protein available from rat mesenteric arteries. The assay mixture consisted of 25 nl [*H]-DHEC, 100 ^1 of the particulate fraction (0.15-0.20 mg protein), and 25 nl of distilled water or various agonists and antagonists dissolved in distilled water. The final ['HJ-DHEC concentration under standard assay conditions was 3-5 nM. After incubation for 20 minutes at 22°C in a gyratory shaker bath, 125 nl aliquots were removed, diluted with 3 ml of assay buffer, and immediately filtered through a Whatman GF/C glass fiber filter. The filter was then washed four times with 5 ml portions of buffer. The filtration system consisted of a single 25 mm filter support (Department of Physiology Shop, Duke University, Durham, NC) mounted on a 1.0 liter filtration flask that was attached, through a flowmeter, to a vacuum line. The flow was adjusted so that 5 ml was filtered in 1-2 seconds. The flowmeter permitted the establishment of constant filtration conditions both within and between experiments. The use of this system permitted the reproducible generation of concentration response curves with a total of only about 200-300 cpm of specific binding. Specific binding was defined as that displacable by 5 pM phentolamine or 100 (-) fig. 1 ). When the saturation curves were analyzed by the method of Scatchard ( fig. 1, insert) , the plot of bound/free [»H]-DHEC versus bound fH]-DHEC described a straight line (r = 0.92), suggesting that [ a H]-DHEC binds to a single class of sites. The equilibrium dissociation constant (K,,) of PHJ-DHEC, represented by the negative reciprocal of the slope, was 2.9 nM. The maximum binding capacity of the site, represented by the x-axis intercept, was 68 fmoles of ["HJ-DHEC per mg of particulate fraction protein.
Kinetics of Binding and Dissociation
Binding was rapid, reaching equilibrium in 6 minutes at 22°C, and remaining stable for at least 20 minutes ( fig. 2) . Since in these experiments the ligand concentration (3 nM) was much greater than receptor concentration (0.1 nM), pseudo-first-order reaction conditions were assumed. The observed forward rate constant (Kob.) was 0.809 min 1 ( fig. 2, insert) , and the calculated second-order rate constant (Ft,) was 6.53 X 10 T min" 1 M"
1 . After equilibrium binding had been obtained, an excess of phcntolaminc (5 /JM) was added to dissociate reversibly bound [
8 H]-DHEC. Dissociation occurred rapidly and was complete by 8 minutes (fig. 3 ). The first-order rate constant for the reverse reaction (k 2 ) was 0.438 min 1 ( fig. 3, insert) . The K < , calculated from the relationship Kj = k,/k\ was 6.7 nM. 
FIGURE 3. Rate of dissociation of [*H]-DHEC from the paniculate fraction of rat mesenteric artery at 22 "C. After equilibrium binding was achieved, an excess of phentolamine (5 fiM) was added to the reaction at time t = 0). Dissociation was complete by
Specificity of ['HJ-DHEC Binding
Displacement of [*H]-DHEC binding by catecholamine agonists followed the a-adrenergic potency series of (-)epinephrine > (-)norepinephrine > (-)isoproterenol ( fig. 4) . The (+)stereoisomers of epinephrine and norepinephrine were less potent in competing with ["HJ-DHEC than were the (-)isomers (fig.  4) . The a-adrenergic antagonist phentolamine (K<, = 3 nM) was 2730 times more potent in competing for ["H]-DHEC binding than was the 0-adrenergic antagonist (i)propranolol (Kj = 8200 nM) ( fig. 5) . Prazosin (K<, = 63 nM), which is relatively specific for post-synaptic, or a x receptors, was 7 and 20 times more potent in displacing ( S H)-DHEC than were clonidine (K^ = 440 nM) and yohimbine (K,, = 1250 nM), which are thought to be relatively specific for presynaptic, or a, receptors. 17 '" Dopamine and serotonin were approximately 100 times less potent in competing with ['HJ-DHEC than were (-)epinephrine and (-)norepinephrine. The catecholamine metabolite normetanephrine inhibited binding only at a high concentration (K,, = 100 /xM), while vanillylmandelic acid did not inhibit binding at 1 mM. The data for all compounds tested are summarized in table 1. ing sites in a stereospecific manner with the potency series of (-)epinephrine > (-)norepinephrine > (-)isoproterenol expected of a-adrenergic receptors." In addition, a-adrcnergic antagonists were several-fold more potent in displacing ['HJ-DHEC than were 0-adrenergic antagonists, while high concentrations of catecholamine precursors and metabolites competed weakly or not at all. Ergot alkaloids, such as dihydroergocryptine, have complex pharmacologic properties and may be either antagonists or partial agonists for dopaminergic or serotonergic as well as a-adrenergic responses." In bovine caudate nucleus, ['HJ-DHEC labels dopaminergic receptors, 1 * and in rat cerebral cortex, possibly serotonergic receptors as well as dopamine receptors." Pharmacologic experiments suggest that serotonergic receptors are present in blood vessels;" and dopaminergic vasodilatory responses have been described in mesenteric as well as renal arteries." It seems unlikely that [*H]-DHEC is binding, however, to any appreciable extent to either dopamine or serotonin receptors in the rat mesenteric artery particulate fraction. Both dopamine and serotonin were less than 1% as potent as (-)epinephrine in competing for [ S H]-DHEC binding sites. Furthermore, the dopamine and serotonin displacement curves (not shown) were smooth and monophasic, thus providing no evidence for the presence of a second population of receptors for these agents. [ S H]-DHEC also appears to label exclusively a-adrenergic receptors in canine aorta.
ALPHA-ADRENERGIC RECEPTORS IN MUSCULAR ARTERIES
11
The rat mesenteric artery particulate fraction that we utilized has certain advantages in comparison to preparations of aortic membranes previously used for vascular receptor studies.*" 11 Presumably, the aorta has been utilized in these studies because it can be readily dissected free of surrounding structures and because of its relatively large mass. In addition to smooth muscle cells, however, blood vessels contain endothelial cells, fibroblasts, varying amounts of connective tissue, and neural elements. Therefore, the likelihood of contamination of a particulate fraction by material from cell types in addition to smooth muscle appears to be greater with the use of fibroelastic as opposed to muscular type arteries, since the latter have a relatively high ratio of smooth muscle to total wall mass. The removal of the adventitia of the mesenteric arteries appears to greatly reduce contamination by neural elements. Evidence for this assertion derives from analysis of the binding data, discussed below. Because of its relatively small mass, the single layer of endothelial cells is unlikely to contribute importantly to the specific ['HJ-DHEC binding of the mesenteric artery fraction. Thus, the density of a-adrenergic receptors in our preparation probably reflects accurately their density in vascular smooth muscle.
There are other advantages to studying vascular receptor mechanisms in muscular rather than fibroelastic arteries. First r since arteries from different vascular beds are pharmacologically heterogeneous, 13 -"• 30 -S1 it is desirable to study mechanisms controlling vascular reactivity directly in muscular arteries that contribute to vascular resistance. Second, since functional innervation appears to be an important determinant of the number of postsynaptic adrenergic receptors, 18 ' "•** the densely innervated mesenteric arteries* 1 would appear to be a more appropriate model for studying physiologic regulation of vascular a-adrenergic receptors than the sparsely innervated aorta." Third, pathologic alteration of aadrenergic receptor function may occur primarily in muscular arteries. Thus, the evidence for increased vascular a-adrenergic sensitivity in the spontaneously hypertensive rat is derived almost exclusively from muscular arteries, 6 -7 including the mesenteric.** In contrast, the aorta of the spontaneously hypertensive rat has not been shown to have increased sensitivity to catecholamines.* 7 Based on physiologic, pharmacologic, and direct biochemical evidence, 17 -"• **"" a-adrenergic receptors may be divided into two subtypes termed a 2 and a a . Alphai receptors are located postsynaptically and mediate classic a-adrenergic effects such as contraction of vascular smooth muscle.* 9 Alphaj receptors are found primarily on presynaptic neurons where they inhibit norepinephrine release. 41 Alphai receptors have been characterized on the human platelet" and therefore are not exclusively presynaptic in location.
The a-adrenergic antagonists, prazosin and yohimbine, are subtype-selective for a t and a, receptors respectively 17 -"• *°-" and, thus, are useful probes for identifying the relative proportion of these subtypes in various tissues. Because the ligand [*H]-DHEC labels both subtypes,"-" the relative potency of prazosin and yohimbine in displacing bound ['HJ-DHEC can provide an index of the proportion of a, and a, subtypes present in a given tissue." With this approach, it has been demonstrated that platelets contain predominantly a,; liver predominantly a t ; and uterus both subtypes of a-adrenergic receptor."
In the rat mesenteric artery particulate fraction the predominant a-adrenergic receptor subtype appears to be a,. Although our method of analysis does not allow a precise quantitation of the proportion of each receptor subtype, there is considerable qualitative evidence to support this conclusion. Thus, prazosin is clearly more potent in displacing ['HJ-DHEC (K^ = 63 nM) than is yohimbine (K,, = 1250 nM). Hoffman et al." have shown that in rat liver, a tissue thought to have 100% a t subtype receptors, prazosin is also more potent than yohimbine in displacing [*HJ-DHEC; whereas in platelets, a tissue thought to have 100% a a subtype receptors, the order of potency is reversed and yohimbine is 400 times more potent than prazosin." Prazosin is considerably more potent than yohimbine in displacing ['HJ-DHEC from the rat mesenteric artery particulate fraction, suggesting that the predominant receptor subtype is similar to that in liver, ai. Supporting this conclusion is the observation that 10" 7 molar yohimbine, a concentration that completely inhibits ['HJ-DHEC binding in the platelet, '••" has no effect at all on binding in the rat mesenteric artery particulate fraction. Finally, the linear Scatchard plot is consistent with a single class of receptors, although it has also been demonstrated that a linear plot may be obtained when the ligand used binds with equal affinity to both receptor subtypes."
In summary, we have used [*H]-DHEC to characterize and to quantify binding sites in rat mesenteric arteries that exhibit the characteristics of a-adrenergic receptors. The a-adrenergic receptors identified are predominantly of the a, subtype that mediates contraction of vascular smooth muscle. The ability to quantitate postsynaptic a-adrenergic receptors in a highly reactive, muscular artery of the type that modulates vascular resistance will facilitate the study of the role of the a-adrenergic receptor in various physiologic states and in animal models of hypertension.
